APA (7th ed.) Citation

D, C., BA, Z., Y, L., P, S., CH, D. O., G, K., . . . DA, G. (2022). MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. Cell metabolism, 34(11), 1732. https://doi.org/10.1016/j.cmet.2022.10.007

Chicago Style (17th ed.) Citation

D, Cheng, et al. "MGAT2 Inhibitor Decreases Liver Fibrosis and Inflammation in Murine NASH Models and Reduces Body Weight in Human Adults with Obesity." Cell Metabolism 34, no. 11 (2022): 1732. https://doi.org/10.1016/j.cmet.2022.10.007.

MLA (9th ed.) Citation

D, Cheng, et al. "MGAT2 Inhibitor Decreases Liver Fibrosis and Inflammation in Murine NASH Models and Reduces Body Weight in Human Adults with Obesity." Cell Metabolism, vol. 34, no. 11, 2022, p. 1732, https://doi.org/10.1016/j.cmet.2022.10.007.